Newron Pharma gets US FDA nod for pivotal phase III ENIGMA─TRS programme with evenamide as add─on therapy in patients ...
Newron Pharmaceuticals S.p.A. (Newron), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announced the approval for its pivotal ENIGMA-TRS phase III …